Tenomix is developing an intelligent automation platform that modernizes cancer pathology by integrating robotics, ultrasound imaging, and AI into existing lab workflows. Tenomix's flagship device, the Lymphonator, automates the lymph node search process in surgically removed tissues: a critical step in cancer staging that is often inconsistent, time-consuming, and costly. Validated through a paid Mayo Clinic pilot and backed by a granted US patent, the Tenomix platform is designed to improve lab efficiency, reduce diagnostic costs, and support more reliable staging decisions.